Results 11 to 20 of about 22,237 (207)

Causes Of Lipodystrophy [PDF]

Journal of Education, Health and Sport, 2018
Korabiusz Katarzyna, Wawryków Agata. Causes of lipodystrophy. Journal of Education, Health and Sport. 2018;8(9):1765-1770. eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1410147 http://ojs.ukw.edu.pl/index.php/johs/article/view/5921 https://pbn.nauka.gov.pl/sedno-webapp/works/876219 The journal has had 7 points in Ministry of ...
Katarzyna Korabiusz, Agata Wawryków
openaire   +6 more sources

European lipodystrophy registry: background and structure [PDF]

Orphanet Journal of Rare Diseases, 2020
Background Lipodystrophy syndromes comprise a group of extremely rare and heterogeneous diseases characterized by a selective loss of adipose tissue in the absence of nutritional deprivation or catabolic state. Because of the rarity of each lipodystrophy
Julia von Schnurbein, Claire Adams, Baris Akinci, Giovanni Ceccarini, Maria Rosaria D’Apice, Alessandra Gambineri, Raoul C. M. Hennekam, Isabelle Jeru, Giovanna Lattanzi, Konstanze Miehle, Gabriele Nagel, Giuseppe Novelli, Ferruccio Santini, Ermelinda Santos Silva, David B. Savage, Paolo Sbraccia, Jannik Schaaf, Ekaterina Sorkina, George Tanteles, Marie-Christine Vantyghem, Camille Vatier, Corinne Vigouroux, Elena Vorona, David Araújo-Vilar, Martin Wabitsch   +24 more
doaj   +2 more sources

Lipodystrophy : focus on HIV Lipodystrophy [PDF]

, 2017
Lipodystrophy is a rare condition which can be inherited or acquired, localised or generalised. It is characterised by abnormal adipose tissue distribution and in some cases underlying metabolic derangement, including diabetes mellitus, hypertriglyceridemia, hepatic steatosis, polycystic ovaries and acanthosis nigricans.
Giordano Imbroll, Miriam, Fenech, Manuel, Gruppetta, Mark   +2 more
core   +4 more sources

Recent developments in lipodystrophy

Current Opinion in Lipidology, 2019
Purpose of review Lipodystrophy syndromes have an estimated prevalence of 1.3–4.7 cases per million and as with other rare diseases conducting research can be challenging. The present review highlights recently published work that has provided insights into the field of non-HIV--associated lipodystrophy syndromes.
Melvin, Audrey, Savage, David, Stears, Anna   +2 more
openaire   +6 more sources

Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review [PDF]

HIV/AIDS: Research and Palliative Care
Tolera Ambisa Lamesa School of Medical Laboratory Science, Jimma University, Jimma, EthiopiaCorrespondence: Tolera Ambisa Lamesa, Email toleraambisa@gmail.comAbstract: Lipodystrophy syndrome is a medical condition characterized by the absence of adipose ...
Lamesa TA
doaj   +1 more source

Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy. [PDF]

, 2013
Highly-active antiretroviral therapy (HAART) can induce a characteristic lipodystrophy syndrome characterized by peripheral fat wasting and central adiposity, usually associated with hyperlipidaemia and insulin resistance [1,2].
Cardellach, Francesc, Pedrol, Enric, Nunes Martínez, Virginia, Casademont i Pou, Jordi, Miró i Andreu, Òscar, Gómez, Montserrat   +5 more
core   +6 more sources

Genetic basis of Asian diabetes. [PDF]

J Diabetes Investig
ABSTRACT Recent genomic studies in Asian populations have advanced our understanding of the diagnosis, pathophysiology, risk prediction, and precision care of diabetes. Monogenic diabetes, including maturity‐onset diabetes of the young (MODY) and mitochondrial diabetes, highlights the importance of genetic diagnosis for subtype‐specific care.
Ojima T, Yamauchi T.
europepmc   +2 more sources

Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis. [PDF]

J Pathol
Abstract Acquired lipodystrophy in the dermal white adipose tissue (DWAT) is an early phenotype of skin fibrosis, followed by the accumulation of extracellular matrix (ECM). Lipodystrophy syndromes are estimated to affect 1 in 20,000 people and are associated with metabolic comorbidities.
Madhavan SR, Moore P, Varshney R, Montegut M, Ma Q, Klatt K, Parameswaran R, Ertugral EG, Kothapalli CR, Rudolph MC, Atit RP.   +10 more
europepmc   +2 more sources

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

Hepatology, EarlyView., 2022
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Abstract Background and Aims Receptor‐interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD)
Marta B. Afonso, Tawhidul Islam, Julie Magusto, Ricardo Amorim, Véronique Lenoir, Rui F. Simões, José Teixeira, Liana C. Silva, Dominique Wendum, Isabelle Jéru, Corinne Vigouroux, Rui E. Castro, Paulo J. Oliveira, Carina Prip‐Buus, Vlad Ratziu, Jérémie Gautheron, Cecília M. P. Rodrigues   +16 more
wiley   +1 more source

Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy

The Turkish Journal of Gastroenterology, 2020
Background/Aims: Lipodystrophy is a rare metabolic disorder characterized by near total or partial lack of subcutaneous adipose tissue and associated with insulin resistance.
Canan Altay, Mustafa Seçil, Süleyman Cem Adıyaman, Başak Özgen Saydam, Tevfik Demir, Gülçin Akıncı, Ilgın Yıldırım Simsir, Erdal Eren, Ela Temeloğlu Keskin, Leyla Demir, Hüseyin Onay, Haluk Topaloğlu, Banu Sarer Yürekli, Nilüfer Özdemir Kutbay, Ramazan Gen, Barış Akıncı   +15 more
doaj   +1 more source